tiprankstipranks
Trending News
More News >
Synlogic (SYBX)
NASDAQ:SYBX

Synlogic (SYBX) Price & Analysis

Compare
565 Followers

SYBX Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

5.77%2.84%53.79%36.04%
53.79% Other Institutional Investors
36.04% Public Companies and
Individual Investors

SYBX FAQ

What was Synlogic’s price range in the past 12 months?
Synlogic lowest stock price was $0.90 and its highest was $1.88 in the past 12 months.
    What is Synlogic’s market cap?
    Synlogic’s market cap is $13.80M.
      When is Synlogic’s upcoming earnings report date?
      Synlogic’s upcoming earnings report date is Aug 07, 2025 which is in 34 days.
        How were Synlogic’s earnings last quarter?
        Synlogic released its earnings results on May 08, 2025. The company reported $0.026 earnings per share for the quarter, beating the consensus estimate of N/A by $0.026.
          Is Synlogic overvalued?
          According to Wall Street analysts Synlogic’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Synlogic pay dividends?
            Synlogic does not currently pay dividends.
            What is Synlogic’s EPS estimate?
            Synlogic’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Synlogic have?
            Synlogic has 11,696,109 shares outstanding.
              What happened to Synlogic’s price movement after its last earnings report?
              Synlogic reported an EPS of $0.026 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 5.357%.
                Which hedge fund is a major shareholder of Synlogic?
                Among the largest hedge funds holding Synlogic’s share is RA Capital Management. It holds Synlogic’s shares valued at 0.

                  Company Description

                  Synlogic

                  Synlogic (SYBX) is a clinical-stage biotechnology company focused on the development of Synthetic Biotic medicines, which are designed to treat diseases by programming probiotics to perform or deliver therapeutic functions in the gut. These engineered probiotics aim to address metabolic and immunological diseases, offering potential treatment options for conditions that are inadequately managed by traditional pharmaceuticals.
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Imunon
                  Phio Pharmaceuticals
                  Moleculin Biotech
                  Marker Therapeutics
                  IN8bio
                  Popular Stocks
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis